4.5 Review

Multicomponent reactions of isocyanides in the synthesis of heterocycles

期刊

RUSSIAN CHEMICAL REVIEWS
卷 79, 期 9, 页码 787-817

出版社

TURPION LTD
DOI: 10.1070/RC2010v079n09ABEH004086

关键词

-

向作者/读者索取更多资源

The latest achievements in the field of isocyanide-based multicomponent reactions for the synthesis of heterocycles are generalized. The attention is focused on the intramolecular Ugi reactions of oxocarboxylic acids and the reactions of diaza nucleophiles developed in recent years. The data on the biological activities of the products are presented and the advantages of this method as a convenient and effective tool of medicinal chemistry are demonstrated. The bibliography inclues 162 references.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor

Galina S. Reshitko, Emil Y. Yamansarov, Sergei A. Evteev, Elena Lopatukhina, Dmitry O. Shkil', Irina Saltykova, Anton Lopukhov, Sergey Kovalev, Alexander N. Lobov, Ivan Kislyakov, Olga Y. Burenina, Natalia L. Klyachko, Anastasiia S. Garanina, Olga A. Dontsova, Yan A. Ivanenkov, Alexander S. Erofeev, Peter Gorelkin, Elena K. Beloglazkina, Alexander G. Majouga

BIOCONJUGATE CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Synthesis and biological activity of 5-aryliden-2-thiohydantoin S-aryl derivatives

Alexander Finko, Dmitry A. Skvortsov, Dimitri N. Laikov, Gleb M. Averochkin, Egor A. Dlin, Marina A. Kalinina, Vladimir A. Aladinskiy, Nataliya S. Vorobyeva, Andrei Mironov, Elena K. Beloglazkina, Nikolay Zyk, Yan A. Ivanenkov, Alexander G. Majouga

BIOORGANIC CHEMISTRY (2020)

Article Chemistry, Organic

Synthesis and Biological Evaluation of Novel Dispiro Compounds based on 5-Arylidenehydantoins and Isatins as Inhibitors of p53-MDM2 Protein-Protein Interaction

Anastasia Beloglazkina, Alexander Barashkin, Vladislav Polyakov, German Kotovsky, Nikita Karpov, Sofia Mefedova, Bogdan Zagribelny, Yan Ivanenkov, Marina Kalinina, Dmitry Skvortsov, Victor Tafeenko, Nikolay Zyk, Alexander Majouga, Elena Beloglazkina

CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2020)

Article Medicine, Research & Experimental

New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma

Rostislav A. Petrov, Sofiia R. Mefedova, Emil Yu Yamansarov, Svetlana Yu Maklakova, Dmitrii A. Grishin, Elena Lopatukhina, Olga Y. Burenina, Anton Lopukhov, Sergey Kovalev, Yury Timchenko, Evgenia E. Ondar, Yan A. Ivanenkov, Sergei A. Evteev, Alexander N. Vaneev, Roman Timoshenko, Natalia L. Klyachko, Alexander S. Erofeev, Petr Gorelkin, Elena K. Beloglazkina, Alexander G. Majouga

Summary: The study developed covalent and low molecular weight docetaxel delivery systems conjugated with N-acetyl-D-galactosamine, showing excellent affinity to ASGPR and high cytotoxicity against hepatocellular carcinoma cells. The glycoconjugates also exhibited significantly increased water solubility and prodrug lability, as well as selective toxicity against hepatoma cells compared to control cell lines. Additionally, specific ASGPR-mediated cellular uptake of the conjugates and enhanced generation of reactive oxygen species in HepG2 cells were observed, highlighting the potential of ASGPR-directed taxane drugs for selective therapy of hepatocellular carcinoma.

MOLECULAR PHARMACEUTICS (2021)

Article Microbiology

Nybomycin Inhibits both Fluoroquinolone-Sensitive and Fluoroquinolone-Resistant Escherichia coli DNA Gyrase

Dmitrii Shiriaev, Alina A. Sofronova, Ekaterina A. Berdnikovich, Dmitrii A. Lukianov, Ekaterina S. Komarova, Valeriya Marina, Yuliya Zakalyukina, Mikhail Biryukov, Tinashe P. Maviza, Yan A. Ivanenkov, Petr Sergiev, Ilya A. Osterman, Olga A. Dontsova

Summary: Bacterial type II topoisomerases are targets of many antibiotics, and some bacteria easily develop resistance to fluoroquinolones through mutations in DNA gyrase or topoisomerase IV genes. Nybomycins are compounds that selectively inhibit growth of some Gram-positive FQ-resistant bacteria, but further research is needed on their effectiveness against Gram-negative species.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Biochemical Research Methods

Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma

Emil Yu Yamansarov, Elena Lopatukhina, Sergei A. Evteev, Dmitry A. Skvortsov, Anton Lopukhov, Sergey Kovalev, Alexander N. Vaneev, Dmitry O. Shkil', Roman A. Akasov, Alexander N. Lobov, Victor A. Naumenko, Ekaterina N. Pavlova, Oxana O. Ryabaya, Olga Yu Burenina, Yan A. Ivanenkov, Natalia L. Klyachko, Alexander S. Erofeev, Petr Gorelkin, Elena K. Beloglazkina, Alexander G. Majouga

Summary: The study describes the design, synthesis, and biological evaluation of novel betulin and N-acetyl-D-galactosamine (GalNAc) glycoconjugates as potential targeted agents against hepatocellular carcinoma. The conjugates exhibited high affinity to hepatocytes and demonstrated moderate cytotoxic activity and selectivity for hepatocellular carcinoma cells. The research suggests that these glycoconjugates could serve as a new strategy for developing therapeutic agents based on natural triterpenoids.

BIOCONJUGATE CHEMISTRY (2021)

Article Chemistry, Medicinal

Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them

Aleksei E. Machulkin, Radik R. Shafikov, Anastasia A. Uspenskaya, Stanislav A. Petrov, Anton P. Ber, Dmitry A. Skvortsov, Ekaterina A. Nimenko, Nikolay U. Zyk, Galina B. Smirnova, Vadim S. Pokrovsky, Maxim A. Abakumov, Irina Saltykova, Rauf T. Akhmirov, Anastasiia S. Garanina, Vladimir Polshakov, Oleg Y. Saveliev, Yan A. Ivanenkov, Anastasiya Aladinskaya, Alexander Finko, Emil U. Yamansarov, Olga O. Krasnovskaya, Alexander S. Erofeev, Petr Gorelkin, Olga A. Dontsova, Elena K. Beloglazkina, Nikolay Zyk, Elena S. Khazanova, Alexander G. Majouga

Summary: PSMA, which is overexpressed in prostate cancer cells, is a suitable target for specific delivery of antitumor drugs and diagnostic agents. The novel PSMA ligands designed exhibit strong inhibition on PSMA activity, with conjugates showing high affinity to PSMA-expressing tumor cells in vitro. In vivo biodistribution of PSMA-SulfoCy5 and PSMA-SulfoCy7 conjugates with a novel PSMA ligand in xenografts demonstrates good visualization of PSMA-expressing tumors, with no explicit toxicity observed up to 87.9 mg/kg.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Antibacterial activity of noscapine analogs

Yan A. Ivanenkov, Kseniya Yu Filyaeva, Rustam T. Matniyazov, Andrey Kh Baymiev, Alexey Kh Baymiev, Anastasiya A. Vladimirova, Renat S. Yamidanov, Ayrat R. Mavzyutov, Zulfia R. Zileeva, Liana F. Zainullina, Julia V. Vakhitova, Valeriya Marina, Victor A. Terentiev, Ilya A. Osterman, Victor G. Kartsev, Dmitry S. Bezrukov, Olga A. Dontsova

Summary: This study identified a series of noscapine derivatives with promising antibacterial activity using a newly developed platform. Some compounds in the series acted by inhibiting the translation machinery in bacteria, showing low toxicity and high selectivity. These compounds demonstrated activity against clinically relevant gram-negative and gram-positive bacterial strains, suggesting their potential as templates for further development and evaluation.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation

Aleksei E. Machulkin, Anastasia A. Uspenskaya, Nikolay Y. Zyk, Ekaterina A. Nimenko, Anton P. Ber, Stanislav A. Petrov, Radik R. Shafikov, Dmitry A. Skvortsov, Galina B. Smirnova, Yulia A. Borisova, Vadim S. Pokrovsky, Vasilii S. Kolmogorov, Alexander N. Vaneev, Yan A. Ivanenkov, Alexander D. Khudyakov, Sergei Kovalev, Alexander S. Erofeev, Petr Gorelkin, Elena K. Beloglazkina, Nikolay Zyk, Elena S. Khazanova, Alexander G. Majouga

Summary: The study focused on developing docetaxel conjugates for prostate cancer treatment, showing promising cytotoxicity and increased solubility compared to the drug itself. In vivo evaluation demonstrated strong inhibitory effects on tumor growth and lower toxicity compared to free docetaxel. The PSMA-targeted docetaxel conjugate is considered a good candidate for further preclinical trials due to its high antitumor activity, reduced side effects, and improved solubility.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Synthesis and Biological Evaluation of S-, O- and Se-Containing Dispirooxindoles

Maksim Kukushkin, Vladimir Novotortsev, Vadim Filatov, Yan Ivanenkov, Dmitry Skvortsov, Mark Veselov, Radik Shafikov, Anna Moiseeva, Nikolay Zyk, Alexander Majouga, Elena Beloglazkina

Summary: A series of novel dispirooxindole derivatives containing S, O, and Se were synthesized and showed good cytotoxicity and selectivity towards colorectal carcinoma cells. Computational study suggested MDM2/p53 interaction as a possible target, but in vitro experiments did not observe significant p53 activation within a relevant concentration range.

MOLECULES (2021)

Article Pharmacology & Pharmacy

From Toxicity to Selectivity: Coculture of the Fluorescent Tumor and Non-Tumor Lung Cells and High-Throughput Screening of Anticancer Compounds

D. A. Skvortsov, M. A. Kalinina, I. V. Zhirkina, L. A. Vasilyeva, Y. A. Ivanenkov, P. V. Sergiev, O. A. Dontsova

Summary: The FCCT method provides a new approach to screening for selectively cytotoxic substances on cancer cells by co-cultivating tumor and non-tumor etiology cells. It is a non-disruptive and high-throughput compatible method that has shown promising results in identifying compounds selectively cytotoxic to cancer cells.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2

Andrey A. Ivashchenko, Bogdan A. Zagribelnyy, Yan A. Ivanenkov, Ilya A. Ivashchenko, Ruben N. Karapetian, Dmitry Kravchenko, Nikolay P. Savchuk, Elena Yakubova, Alexandre Ivachtchenko

Summary: This study demonstrated the high efficacy of aprotinin combinations with selected antiviral drugs in the treatment of influenza virus and coronavirus infections. It serves as a crucial confirmation step for clinical assessment.

MOLECULES (2022)

Article Multidisciplinary Sciences

Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission

Jeremy C. Jones, Bogdan Zagribelnyy, Philippe Noriel Q. Pascua, Dmitry S. Bezrukov, Subrata Barman, Faten Okda, Richard J. Webby, Yan A. Ivanenkov, Elena A. Govorkova

Summary: The E23G/K substitutions play an important role in reducing the susceptibility of Baloxavir marboxil (BXM). These substitutions, especially when combined with the PA I38T resistance marker, significantly increase resistance to BXM. Additionally, the E23G/K substitutions impair virus replication and transmission to some extent.

PLOS ONE (2022)

Article Chemistry, Medicinal

Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine epsilon-nitrogen atom

Nikolai Y. Zyk, Anton P. Ber, Ekaterina A. Nimenko, Radik R. Shafikov, Sergei A. Evteev, Stanislav A. Petrov, Anastasia A. Uspenskaya, Natalia S. Dashkova, Yan A. Ivanenkov, Dmitry A. Skvortsov, Elena K. Beloglazkina, Alexander G. Majouga, Aleksei E. Machulkin

Summary: An improved series of ligands targeting PSMA were designed with changes in the aromatic fragment structure, resulting in improved biological parameters. Some compounds showed high selectivity and nanomolar IC50 values. Two conjugates with a fluorescent label were synthesized and tested, demonstrating the potential for using PSMA inhibitors for diagnostic preparations.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Imidazole Derivative As a Novel Translation Inhibitor

D. A. Lukianov, V. S. Buev, Y. A. Ivanenkov, V. G. Kartsev, D. A. Skvortsov, I. A. Osterman, P. Sergiev

Summary: Searching for novel compounds with antibiotic activity and understanding their mechanism of action is crucial. In this study, the compound 1-(2-oxo-2-((4-phenoxyphenyl)amino)ethyl)-3-(p-tolyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-1-ium chloride was found to inhibit protein synthesis both in vivo and in vitro, providing valuable information for the modification of translational inhibitors.

ACTA NATURAE (2022)

暂无数据